Fuad El-Rassi (Fuad El Rassi)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Palliative Care

Sickle Cell Disease

Cross Sectional

Top Venues

American journal of hematology

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Carlton D Dampier, Marilyn J Telen, Ted Wun, Clark Brown, Payal Chandarana Desai, Fuad El-Rassi, Beng Fuh, Julie Kanter, Yves D Pastore, Jennifer A Rothman, James G Taylor, David Readett, Krupa M Sivamurthy, Brinda Tammara, Li-Jung Tseng, Jay Nelson Lozier, Helen M Thackray, John L Magnani, Kathryn Hassell
A Randomized Clinical Trial of the Efficacy and Safety of Rivipansel for Sickle Cell Vaso-occlusive Crisis (VOC). Blood (2022)
Lakshmanan Krishnamurti, Staci D Arnold, Ann Haight, Allistair A Abraham, Gregory M T Guilcher, Tami D John, Nitya Bakshi, Shalini Shenoy, Karen L Syrjala, Paul L Martin, Sonali Chaudhury, Gretchen Eames, Olusola Festus Olowoselu, Matthew M Hsieh, Josu de la Fuente, Kimberly A Kasow, Elizabeth Stenger, Anne W J Martens, Fuad El-Rassi, Peter Lane, Bronwen E Shaw, Lillian R Meacham, David R Archer
Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study. JMIR research protocols 11 (7) (2022)
Ifeyinwa Osunkwo, John James, Fuad El-Rassi, Alecia Nero, Caterina P Minniti, Cassandra Trimnell, Jincy Paulose, Nicholas Ramscar, Tom Bailey, Olivera Rajkovic-Hooley, Biree Andemariam
Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high- and low- to middle-income countries for the international Sickle Cell World Assessment Survey. American journal of hematology 97 (8) (2022)